Checking chemotherapy before and after surgery for high-risk sarcoma
Part of Cancer clinical trials.
This Phase 3 trial tests whether giving chemotherapy around the time of surgery (before/after) can improve outcomes for people with high-risk localized soft-tissue sarcoma. It uses special tumor testing (CINSARC) to help identify higher-risk patients who may benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of soft-tissue sarcoma from an approved pathology network
- Your tumor is localized (not spread to other organs) and can be removed with surgery
- You had surgery within the last 6 weeks (if surgery happened before trial enrollment)
- You must have an available stored tumor tissue sample that can be tested for CINSARC
- You’re age 18 or older, and can manage daily activities reasonably well (ECOG 0–2)
- You can use effective birth control during treatment and for a period after (details depend on the drug)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a step-by-step (sequential) chemotherapy plan given before surgery for adults with specific types of soft tissue sarcoma. The goal is to shrink or control the tumor before the operation and see how well this approach works and is tolerated.
This trial tests combining anlotinib (a targeted therapy), doxorubicin (chemotherapy), and radiation given before surgery to shrink high-grade soft tissue sarcomas. The goal is to make the tumor easier to remove and improve outcomes.
This trial tests a combination of immunotherapy (atezolizumab), chemotherapy (doxorubicin), and radiation before and after surgery for people with high-risk soft tissue sarcoma in the arm, leg, or trunk. The goal is to see if this approach can improve outcomes.
This trial tests a new immunotherapy drug (envafolimab) combined with two chemotherapy drugs (doxorubicin and ifosfamide) for people with advanced soft tissue sarcoma who have not had prior treatment. The goal is to see if this combination is safe and effective.
This trial tests if a powerful type of radiation called carbon ion therapy, given before surgery, is safe and effective for treating soft tissue sarcoma. It may help shrink the tumor before it’s removed.
This trial tests a new approach for high-risk soft tissue sarcoma of the arm, leg, or trunk. Before surgery, you would receive chemotherapy combined with local hyperthermia (a treatment that gently heats the tumor area) to see if this can improve outcomes.
Hear when a new Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.